Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries

24. juli 2014 oppdatert av: GlaxoSmithKline

To Evaluate Incidence of Acute Otitis Media in Children Aged < 6 Years in Five East European Countries

The aim of this study is to provide baseline acute otitis media data in East European countries.

Studieoversikt

Detaljert beskrivelse

Each subject's involvement in this study will include a retrospective and prospective part.

Studietype

Observasjonsmessig

Registrering (Faktiske)

2258

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

      • Tallinn, Estland, 10621
        • GSK Investigational Site
      • Vilnius, Litauen, LT-07156
        • GSK Investigational Site
      • Vilnius, Litauen, LT-04318
        • GSK Investigational Site
      • Vilnius, Litauen, LT-03147
        • GSK Investigational Site
      • Bydgoszcz, Polen, 85-796
        • GSK Investigational Site
      • Debica, Polen, 39-200
        • GSK Investigational Site
      • Katowice, Polen, 40-018
        • GSK Investigational Site
      • Kielce, Polen, 25-711
        • GSK Investigational Site
      • Leczna, Polen, 21-010
        • GSK Investigational Site
      • Siemianowice Slaskie, Polen, 41-103
        • GSK Investigational Site
      • Tarnow, Polen, 33-100
        • GSK Investigational Site
      • Warszawa, Polen, 01-809
        • GSK Investigational Site
      • Wejherowo, Polen, 84-200
        • GSK Investigational Site
      • Wola, Polen, 43-225
        • GSK Investigational Site
      • Bacau, Romania, 600316
        • GSK Investigational Site
      • Brasov, Romania, 500260
        • GSK Investigational Site
      • Bucharest, Romania, 051821
        • GSK Investigational Site
      • Craiova, Romania, 200128
        • GSK Investigational Site
      • Galati, Romania, 800394
        • GSK Investigational Site
      • Ljubljana, Slovenia, 1000
        • GSK Investigational Site
      • Ljubljana, Slovenia, 1210
        • GSK Investigational Site
      • Maribor, Slovenia, 2000
        • GSK Investigational Site
      • Maribor, Slovenia
        • GSK Investigational Site
      • Ptuj, Slovenia, 2250
        • GSK Investigational Site
      • Ruše, Slovenia, 2342
        • GSK Investigational Site

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

Ikke eldre enn 6 år (Barn)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Subjects aged < 6 years who are registered in primary care clinics of any of the participating countries (Estonia, Lithuania, Poland, Romania and Slovenia) will be enrolled in this study.

Beskrivelse

Inclusion Criteria:

  • Subjects who the investigator believes that parent(s)/ legally acceptable representative(s) can and will comply with the requirements of the protocol.
  • A male or female subject aged < 6 years at the time of enrolment.
  • The investigator has access to the medical records that contain the medical history of the subjects for one year prior to enrolment (for subjects aged 1 to < 6 years) or from birth (for subjects aged < 1 year).
  • Written informed consent obtained from either both parents/ LARs or from one parent/ LAR of the subject with the declaration of cooperation for one year after enrolment.

Exclusion Criteria:

  • Acute otitis media episode at the time of enrolment.
  • Upper respiratory tract infection at the time of enrolment.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Kohorter og intervensjoner

Gruppe / Kohort
Intervensjon / Behandling
Cohort A
Subjects aged < 6 years who are registered in primary care clinics of any of the participating countries (Estonia, Lithuania, Poland, Romania and Slovenia).
For the retrospective part of the study, the parent(s)/ legally acceptable representative(s) of the subjects will be interviewed to collect information on factors potentially related to risk for middle ear diseases. The medical records of the subjects will also be reviewed and all acute otitis media related problems that occurred during the last year prior to enrolment (for subjects aged 1 to < 6 years) or since birth (for subjects aged < 1 year) will be recorded in the electronic case report form.
For the prospective part of the study, the enrolled subjects will be followed up for a period of 1 year starting from the consent date, during which the parent(s)/ legally acceptable representative(s) will be asked to bring the subject for a visit each time they notice symptoms of acute otitis media or respiratory tract infection in the subject. In case AOM is diagnosed by the investigator, detailed information on the signs, symptoms, severity, course and treatment will be recorded. The parent(s)/ legally acceptable representative(s) of the subjects will also be required to fill up a parental quality of life questionnaire and an Otitis Media-6 children's quality of life questionnaire.

Hva måler studien?

Primære resultatmål

Resultatmål
Tidsramme
Occurrence of acute otitis media in subjects aged < 6 years as diagnosed by a family physician and documented in medical records - retrospective part of the study
Tidsramme: Retrospective data for 12 months prior to study entry for subjects aged > 1 year or for the entire period since birth for subjects aged < 1 year
Retrospective data for 12 months prior to study entry for subjects aged > 1 year or for the entire period since birth for subjects aged < 1 year
Occurrence of acute otitis media in subjects aged < 6 years as diagnosed by the physician or specialist - prospective part of the study
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry

Sekundære resultatmål

Resultatmål
Tidsramme
Prevalence of otitis media with effusion among acute otitis media cases aged < 6 years in the four consecutive seasons of the year
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Occurrence of suspected acute otitis media as reported by the parent(s)/ legally acceptable representative(s) (and not diagnosed by any physician) during the bi-monthly follow-up
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Occurrence of recurrent acute otitis media
Tidsramme: Retrospective data for 12 months prior to study entry for subjects aged > 1 year or for the entire period since birth for subjects aged < 1 year and prospective data for 12 months after study entry
Retrospective data for 12 months prior to study entry for subjects aged > 1 year or for the entire period since birth for subjects aged < 1 year and prospective data for 12 months after study entry
Occurrence of acute otitis media treatment failures
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Assessment of the impact of acute otitis media on the quality of life of the subject and family by the parental quality of life questionnaire and the Otitis Media-6 children's quality of life questionnaire
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Direct medical, direct non-medical costs and indirect medical costs of one incident of acute otitis media
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Occurrence of acute otitis media as diagnosed by the study physician or any other doctor
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry
Use of antimicrobial therapy and other forms of treatment for acute otitis media, diagnostic procedures
Tidsramme: Prospective data for 12 months after study entry
Prospective data for 12 months after study entry

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. juni 2011

Primær fullføring (Faktiske)

1. desember 2012

Studiet fullført (Faktiske)

1. desember 2012

Datoer for studieregistrering

Først innsendt

31. mai 2011

Først innsendt som oppfylte QC-kriteriene

1. juni 2011

Først lagt ut (Anslag)

3. juni 2011

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

28. juli 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

24. juli 2014

Sist bekreftet

1. mai 2014

Mer informasjon

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere